Rx-to-OTC Switch
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Perrigo Ships Opill To Stores, But Contraceptive Access Advocates Say It Doesn’t Deliver On Price
First US OTC daily oral contraceptive shipped to major retailers and pharmacies and will be available on shelves nationwide and online later in March. Perrigo says pre-orders for Opill are available currently from select online retailers.
OTC Naloxone Pioneer Emergent BioSolutions Puts Papa At Helm As It Navigates Strategy Shift
Like his previous move, Papa joins a pharma firm making a significant organizational shift to cut costs and increase revenues after extended period of higher spending and slowing income.
Petros Pharma Introduces AI As ACNU Option In Research For OTC Switch Of Stendra ED Drug
Petros is first to introduce an OTC switch labeling tool which could be the next obvious step hiding in plain sight – AI, which wasn’t noted in FDA’s ACNU proposal and hasn’t previously been linked to a switch.
UK Doctors Call For Mass Market Access To Emergency Contraceptive Pill
UK doctors are calling for the reclassification of oral emergency hormonal contraceptives (EHCs) from pharmacy (P) medicine status to general sales list (GSL) status in the country. Manufacturer Maxwellia, which markets levonorgestrel-based emergency contraception, LoviOne, says it "has what it takes to get this over the line" with the UK Medicines and Healthcare products Regulatory Agency.
Sanofi Awaiting Key Meeting With FDA To Recommence Cialis Switch
Sanofi is waiting to hear from FDA whether it has done enough to recommence its Cialis actual-use trial, which has been on hold for almost two years. The France-based firm gave an update on the Cialis switch program as it reported higher Consumer Healthcare sales in Q4.
Pressure On Opill Price From Lawmakers, Health Advocates, Not From Marketplace Competition
Pressure from members of Congress and public and reproductive health advocacy groups will continue for making Opill’s price affordable to consumers from all income levels, but competition won’t affect the price for three years.
Perrigo’s Rx-To-OTC Contraceptive Pill Switch Unanimously Rejected By German Committee
All nine present voting members of Germany's Expert Committee for Prescription rejected Perrigo's application to switch its progestogen-only contraceptive pill (desogestrel 75μg) from Rx to OTC status.
US Q4 Consumer Health Earnings Preview: Supply Chain Disruption Returns, Opill Launch Waits
Attacks on shipping since November in the Red Sea lead shipping lines to re-route vessels south of Africa, spiking shipping costs. Perrigo began 2024 saying it expects sales of Opill oral contraceptive to start early in the first quarter, but now expects to start late in the quarter.
Hanmi's Merger Plan Could Spark Power Struggle In South Korea Pharma Sector
An unexpected merger between Korea's Hanmi Pharm Group and chemical group OCI may raise eyebrows in terms of likely synergies, but analysts are viewing the planned transaction positively in terms of future cash flow. However, resistance from some members of Hanmi's founder family may mean a possible leadership struggle at the pharma company.
OTC Narcan’s Shelf-Life Extended A Year, RiVive Naloxone Shipments Launched To Nonprofits
Emergent extends shelf-life of newly manufactured Narcan from three years to four years at FDA’s request; nonprofit pharma Harm Reduction Therapeutics ships first order of RiVive to overdose prevention advocacy group Remedy Alliance/For the People.
Association Focus In 2024: Self-Care, Sustainability And Prospects For Political ‘Reorientation’
Association leaders offer views on key challenges, priorities and opportunities for the self-care industry in 2024, including potential political redirections following elections in the US and Europe.
Consumer Health In 2024: ‘Switch Power,’ ‘Reframing Sustainability’ And Meeting Household Budgets
Views from industry leaders and experts on the biggest trends, challenges and opportunities facing consumer health in the new year.
First US OTC Oral Contraceptive, Opill Marks Start Of Perrigo's Women’s Health ‘Mega-Brand’
“We do want to be a mega brand offering solutions across the women's sexual health journey. From the moment she enters into that category all the way through to post menopause, including fertility, we will develop out a mega brand,” says CEO Patrick Lockwood-Taylor.
Sanofi Secures First EU Market Approval for OTC Cialis
Following an application through the decentralised procedure, Ireland is the first EU member state to approve Sanofi's Cialis (tadalafil) for non-prescription sale. An OTC version of the blockbuster erectile dysfunction treatment has also been given the green light in Norway, but Germany has rejected the product.
The Future Of US FDA’s Institutional Memory
Upcoming retirement of Janet Woodcock will mean loss of one of agency's FDA’s most experienced and influential drug regulators. However, CDER still has plenty of long-tenured staff peppered across all its key functions.
OTC Marketing Awards 2023: What The Judges Said About The Leading Entries
The trophies have been presented at the OTC Marketing Awards 2023 - but what did the judging panel have to say about the winning and highly-commended entries?
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.